If a prescription for a controlled substance in Schedule III, IIIN, IV, and/or V is initiated by the approved supervising, collaborating or covering physician AND the patient is well maintained on the medication, the QACSC holder may authorize no more than 30 days with two (2) reissues or ninety (90) days total.  Please read the attachment or click on the below link for more information: 

http://www.albme.org/Documents/QACSC-LPSPprotocol.pdf